BDBM323236 N-[2-(3-butoxy-3-o-tolylazetidin-1-yl)-1-(2,4-dichlorobenzyl)-2-oxoethyl]-3-(1H-imidazol-4-yl)hexylamide::US9630949, 65

SMILES CCCCOC1(c2ccccc2C)CN(C(=O)C(Cc2ccc(Cl)cc2Cl)[N-]CCC(CCC)c2c[nH]cn2)C1

InChI Key InChIKey=GSLZVKBEDSMHAT-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 323236   

TargetMelanocortin receptor 4(Human)
Galderma Research & Development

US Patent
LigandChemical structure of BindingDB Monomer ID 323236BDBM323236(N-[2-(3-butoxy-3-o-tolylazetidin-1-yl)-1-(2,4-dich...)
Affinity DataEC50:  100nMAssay Description:In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2019
Entry Details
US Patent